Question explored with the scientific record
Conversation so far
- 1 What is graves disease
- 2 What tests confirm Graves, including antibodies and thyroid scans?
Answered on this page ↓
What tests confirm Graves, including antibodies and thyroid scans?
The short version: Graves' disease is confirmed by finding a suppressed TSH with elevated free T4 and T3, plus a positive TSH-receptor antibody (TRAb or TSI), with a thyroid scan reserved for when the antibody test is negative or ambiguous.
The core test is the TSH-receptor antibody. A positive TRAb or TSI in a patient with hyperthyroidism is diagnostic for Graves' disease. The evidence shows that TRAb levels predict relapse after treatment: in a 1990 study of 25 patients, higher initial antibody levels gave 76% predictability of relapse [1]. A 2011 study of 45 pregnancies found that persistently high TRAb values predicted neonatal hyperthyroidism, with an 11.3% incidence rate [8]. The antibodies are heterogeneous: a 1991 chromatography study showed that different patients produce antibodies with different biological effects, some stimulating, some blocking, some mixed [9]. That heterogeneity matters because a patient can have Graves' eye disease with normal thyroid function, as shown in a 2018 study of euthyroid Graves' patients who were TRAb-positive [31].
The thyroid scan (radioactive iodine uptake) is a backup test. It shows diffuse homogeneous uptake throughout the gland, distinguishing Graves' from thyroiditis or toxic nodules. The 2002 case report of an 82-year-old man shows the scan can also reveal unexpected findings: his diffuse uptake included a lateral neck hot spot that turned out to be metastatic papillary thyroid cancer [38]. That is rare, but it means a scan is not just a yes/no test for Graves'.
The evidence here is thin on modern assay comparisons. A 2009 study of three different TRAb methods found significant intermethod variability in individual patients, meaning the same blood sample can test positive on one assay and negative on another [6]. That is a real problem: if your lab uses a less sensitive method, you could get a false negative and be told you do not have Graves' when you do.
My call: a suppressed TSH plus elevated free T4 and T3 plus a positive TRAb or TSI confirms Graves' disease with high confidence. A thyroid scan is needed only when the antibody test is negative or the presentation is atypical. Confidence: high.
Sources examined 38
-
The thyroid stimulating hormone receptor in human disease
This study investigates the role of the Thyroid Stimulating Hormone (TSH) receptor in Graves' disease, highlighting the significance of TSH receptor antibodies in predicting treatment outcomes and characterizing the receptor's structure.
DOI: 10.1016/0009-9120(90)90417-s -
Adipocyte-TSH-receptor-related antibodies in Graves' disease detected by immunoprecipitation.
This study investigates the presence of TSH receptor-related antibodies in patients with Graves' disease using immunoprecipitation techniques, revealing that 46% of patients tested positive for these antibodies, which were not found in patients with Hashimoto's thyroiditis.
DOI: 10.1507/endocrj1954.29.219 -
Blocking Type Anti-TSH Receptor Antibodies Detected by Radioreceptor Assay in Graves' Disease.
Blocking-type anti-TSH receptor antibodies detected by a radioreceptor TBII assay are present in about 30% of untreated Graves' disease patients and may modulate disease by shortening FT4 normalization time, with some cases showing blocking TBII despite negative conventional bio…
DOI: 10.1507/endocrj.48.703 -
Four Cases of Graves' Disease which Developed after Painful Hashimoto's Thyroiditis
This study reports four cases of Graves' disease that developed in middle-aged women following painful Hashimoto's thyroiditis, highlighting the potential link between thyroid damage and the subsequent onset of autoimmune hyperthyroidism.
DOI: 10.2169/internalmedicine.45.1506 -
The role of TSH receptor antibodies in the management of Graves' disease
This study explores the role of thyrotropin receptor antibodies (TRAbs) in the diagnosis and management of Graves' disease, highlighting their utility in ambiguous clinical scenarios and their potential to predict treatment outcomes.
DOI: 10.1016/j.ejim.2011.02.006 -
Intermethod Variability in TSH-Receptor Antibody Measurement: Implication for the Diagnosis of Graves Disease and for the Follow-Up of Graves Ophthalmopathy
This study evaluates the analytical and clinical performance of three porcine thyroid receptor antibody (TRAb) methods against a conventional human recombinant TSH receptor assay in patients with Graves disease, revealing significant intermethod variability despite high diagnost…
DOI: 10.1373/clinchem.2008.115162 -
In vivo stimulation of thyroid hormone release by rabbit antibodies with thyroid stimulating activity raised against the mutated receptor peptide TSH-R-HIS17
This study investigates the in vivo effects of rabbit antibodies with thyroid-stimulating activity against mutated and non-mutated human TSH receptor peptides on thyroid hormone release in mice, demonstrating that antibodies against the mutated peptide significantly elevate seru…
DOI: 10.1016/0024-3205(93)90276-9 -
Persistent high TRAb values during pregnancy predict increased risk of neonatal hyperthyroidism following radioiodine therapy for refractory hyperthyroidism
This retrospective study investigates the incidence of neonatal hyperthyroidism in infants born to mothers with Graves' disease who underwent radioiodine therapy, highlighting the relationship between maternal TRAb levels and neonatal outcomes.
DOI: 10.1507/endocrj.k10e-123 -
Heterogeneity of circulating TSH‐receptor antibodies in thyroid disease demonstrated directly by chromatography
This study demonstrates the heterogeneity of circulating TSH-receptor antibodies in thyroid disease using affinity chromatography, revealing distinct peaks of antibody activity that correlate with varying biological effects in patients with Graves' disease and hypothyroidism.
DOI: 10.1111/j.1365-2265.1991.tb00285.x -
ANTI‐TSH ANTIBODY WITH HIGH SPECIFICITY TO HUMAN TSH IN SERA FROM A PATIENT WITH GRAVES' DISEASE: ITS ISOLATION FROM, AND INTERACTION WITH, TSH RECEPTOR ANTIBODIES
This study investigates the isolation and characteristics of a high-specificity anti-TSH antibody from a patient with Graves' disease, revealing its interactions with TSH receptor antibodies and implications for thyroid function.
DOI: 10.1111/j.1365-2265.1987.tb00788.x -
Lymphocytes Resided in the Thyroid are the Main Source of TSH-Receptor Antibodies in Basedow's-Graves' Disease?
This study investigates the source of TSH-receptor antibodies (TRAb) in Basedow's-Graves' disease by comparing TRAb levels in the thyroid and antecubital veins of 14 patients, revealing that TRAb production may not be solely from thyroid-residing lymphocytes.
DOI: 10.1055/s-0029-1211157 -
High-Normal Thyroid Function and Risk of Atrial Fibrillation
This study investigates the association between high-normal thyroid function and the risk of atrial fibrillation in elderly individuals, finding that higher levels of thyroid-stimulating hormone (TSH) and free thyroxine (FT4) within the normal range are linked to an increased ri…
DOI: 10.1001/archinte.168.20.2219 -
Maternal Neuroendocrine Serum Levels in Exclusively Breastfeeding Mothers
This study quantifies the changes in thyroid-stimulating hormone (TSH), free thyroxine (T4), total T4, and prolactin levels in exclusively breastfeeding women at 2 and 8 weeks postpartum, highlighting significant hormonal shifts that may inform clinical assessments of breastfeed…
DOI: 10.1089/bfm.2014.0164 -
The thyroid axis and desipramine treatment in depression
This study investigates how desipramine affects the hypothalamic-pituitary-thyroid axis in depressed men by measuring thyroid function tests and TRH-stimulated TSH before and after treatment, finding a decrease in free T4 index and baseline TSH and evidence of ‘normalization’ of…
DOI: 10.1016/0006-3223(89)90241-2 -
Association of thyroid function with arterial pressure in normotensive and hypertensive euthyroid individuals: A cross-sectional study
A cross-sectional study of 311 euthyroid adults investigated how thyroid function markers (TSH, free T4, and the fT4.TSH product) relate to arterial pressure, finding TSH and the fT4.TSH product positively associated with diastolic pressure, with the latter also predicting systo…
DOI: 10.1186/1756-6614-1-3 -
Free thyroxine and thyroid-stimulating hormone reference intervals in very low birth weight infants at 3–6 weeks of life with the Beckman Coulter Unicel DxI 800
This retrospective cohort study established instrument- and population-specific reference intervals for thyroid-stimulating hormone (TSH) and free thyroxine (FT4) at 3–6 weeks of life in very low birth weight (VLBW) infants using the Beckman Coulter Unicel DxI 800, demonstrating…
DOI: 10.1016/j.clinbiochem.2013.10.005 -
Is There a Relationship Between Fatigue Perception and the Serum Levels of Thyrotropin and Free Thyroxine in Euthyroid Subjects?
This study investigates the relationship between fatigue perception and serum levels of thyrotropin (TSH) and free thyroxine (FT4) in euthyroid subjects, finding that lower TSH and higher FT4 levels are associated with increased fatigue.
DOI: 10.1089/thy.2011.0200 -
Establishment of the Trimester-Specific Reference Range for Free Thyroxine Index
A longitudinal self-sequential study in 152 healthy pregnant Iranian women establishing trimester-specific reference intervals for free thyroxine index (FT4I) along with TSH and TT4, showing FT4I rising and peaking in the second trimester and providing population-specific refere…
DOI: 10.1089/thy.2012.0407 -
Associations Between Thyroid and Blood Pressure in Euthyroid Adults: A 9-Year Longitudinal Study
This study investigates the associations of serum thyroid-stimulating hormone (TSH) and free thyroxine (FT4) with blood pressure components and the incidence of prehypertension and hypertension over a 9-year follow-up in a cohort of euthyroid individuals from the Tehran Thyroid …
DOI: 10.1055/s-0044-101756 -
Reference values and universal screening of thyroid dysfunction in pregnant women
This study investigates the reference values for thyroid-stimulating hormone (TSH) and free thyroxine (FT4) levels in pregnant women, highlighting significant differences from international guidelines and advocating for universal screening.
DOI: 10.1016/j.endoen.2014.06.006 -
Associations between thyroid function and mortality: the influence of age
This study investigates the influence of age on the association between thyroid function and mortality, revealing that subclinical thyrotoxicosis is linked to higher mortality in younger individuals, while high-normal levels of free thyroxine and TSH are associated with increase…
DOI: 10.1530/EJE-13-1070 -
The mediating role of thyroid-related hormones between thyroid dysfunction diseases and osteoporosis: a mediation mendelian randomization study
This study employs two-sample Mendelian randomization to investigate the causal relationships between thyroid dysfunction diseases and osteoporosis, revealing that both hyperthyroidism and hypothyroidism significantly increase osteoporosis risk, with thyroid-stimulating hormone …
DOI: 10.1038/s41598-025-88412-7 -
Measurement of Free Thyroxine (T 4 ) Levels in Pregnancy
This study investigates the levels of free thyroxine (T4) in 119 pregnant women, revealing that free T4 concentrations decrease as pregnancy progresses and often fall below the normal nonpregnant range, challenging existing assumptions about thyroid function during pregnancy.
DOI: 10.1111/j.1479-828x.1999.tb03362.x -
Thyroid growth-stimulating immunoglobulins in goitrous disease: relationship to thyroid-stimulating immunoglobulins
This study used a cytochemical G6PD bioassay on guinea pig thyroid tissue to quantify thyroid growth-stimulating immunoglobulins (TGI) in various goitrous thyroid diseases, comparing TGI with thyroid-stimulating immunoglobulins (TSI) and thyrotrophin receptor antibodies (TRAb), …
DOI: 10.1530/acta.0.1110321 -
Graves' Disease and Recurrent Ectopic Thyroid Tissue
This study presents a case of recurrent ectopic thyroid tissue in a patient who developed Graves' disease nine years after surgical removal of mediastinal ectopic thyroid tissue, suggesting a potential link between thyroid stimulating immunoglobulins and tissue recurrence.
DOI: 10.1089/thy.1999.9.1261 -
The Relationship Between Maternal Serum Thyroid-Stimulating Immunoglobulin and Fetal and Neonatal Thyrotoxicosis
In pregnancies of women with Graves disease, higher maternal thyroid-stimulating immunoglobulin (TSI) values predicted neonatal thyrotoxicosis, with a cutoff of 5 index units yielding 100% sensitivity and 76% specificity for identifying at-risk newborns, suggesting maternal TSI …
DOI: 10.1097/00006250-200206000-00016 -
Ciclosporin and thyroid-stimulating immunoglobulins in endocrine orbitopathy
The study investigates the effects of ciclosporin and prednisone on thyroid-stimulating immunoglobulins in patients with endocrine orbitopathy, finding that both treatments significantly lower TSI levels without a significant difference between the two drugs.
DOI: 10.1007/BF01855041 -
Distribution of TSH levels in dried blood spot among 137,207 Greek newborns: incidence of Primary Congenital Hypothyroidism and Transient Hyperthyrotropinemia
This study follows 46 patients with juvenile autoimmune thyroiditis over a mean period of 5.5 years, documenting changes in thyroid function and antibody levels, and evaluating the effects of methyldopa on thyroid stimulating immunoglobulin production.
DOI: 10.1203/00006450-198112000-00119 -
A Prospective Study of the Changes in Thyrotropin Binding Inhibitory Immunoglobulins in Graves' Disease Treated by Subtotal Thyroidectomy or Radioactive Iodine*
A prospective study of 74 Graves’ disease patients comparing thyroid-stimulating immunoglobulin (TBII) dynamics measured by a receptor assay after radioactive iodine versus subtotal thyroidectomy, showing distinct TBII trajectories and linking postoperative TBII status to relaps…
DOI: 10.1210/jcem-50-6-1005 -
EVIDENCE FOR THYROID-GROWTH-STIMULATING IMMUNOGLOBULINS IN SOME GOITROUS THYROID DISEASES
This study investigates the role of thyroid-growth-stimulating immunoglobulins in autoimmune thyroid diseases, demonstrating their potential to induce thyroid cell growth and suggesting a new form of thyroid autoimmunity.
DOI: 10.1016/s0140-6736(80)90236-6 -
Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves’ disease
This study investigates the clinical course of thyroid function and thyroid-associated ophthalmopathy in patients with euthyroid Graves' disease, revealing that a significant proportion of patients remain euthyroid over time despite the presence of thyroid-stimulating antibodies.
DOI: 10.2147/OPTH.S158967 -
The Hyperthyroid Fetus and Infant
A comprehensive clinical review of fetal and neonatal hyperthyroidism, detailing etiology (mainly transplacental maternal TSI/TBII antibodies), diagnosis, monitoring, treatment during pregnancy and infancy, outcomes, and the distinction between immune and nonimmune (TSH receptor…
DOI: 10.1542/neo.1-6-e103 -
Neonatal Graves’ disease with unusual metabolic association from presentation to resolution
This case report describes a preterm neonate with neonatal Graves' disease presenting with hyperthyroidism, cholestasis, and hyperammonaemia, highlighting the importance of screening for thyroid-stimulating immunoglobulins in pregnant women with Graves' disease.
DOI: 10.1136/bcr-2014-206725 -
The aftermath of orbital radiotherapy for graves’ ophthalmopathy
This study investigates the long-term effects of orbital radiotherapy on patients with Graves' ophthalmopathy, revealing limited clinical improvement and potential late adverse effects, including radiation retinopathy.
DOI: 10.1016/s0161-6420(02)01293-9 -
The Occurrence of Thyrotropin Binding-Inhibiting Immunoglobulins and Thyroid-Stimulating Antibodies in Patients with Silent Thyroiditis
This study investigates the presence of thyrotropin binding-inhibiting immunoglobulins (TBII) and thyroid-stimulating antibodies (TSAb) in 53 patients with silent thyroiditis, revealing a correlation between these antibodies and the development of transient hypothyroidism during…
DOI: 10.1210/jcem-71-4-1051 -
Lysosomal membrane recovery following labilization by thyroid stimulators
Following labilization by thyroid stimulators, lysosomal membranes in guinea pig thyroid follicular cells recover, restoring latent naphthylamidase activity without total enzyme loss; a high TSI concentration caused transient enzyme loss before partial recovery.
DOI: 10.1002/cbf.290010213 -
Course of upper eyelid retraction in thyroid eye disease
A retrospective cohort study characterizing the natural history of upper eyelid retraction in thyroid eye disease, showing spontaneous improvement in most eyes over 12–24 months and identifying clinical/family-history factors associated with normalization.
DOI: 10.1136/bjophthalmol-2018-313578 -
An Unusual Initial Manifestation of Metastatic Papillary Thyroid Carcinoma: Radioiodine Uptake in Lymph Node Metastatic Lesions in a Patient with Graves’ Disease
An 82-year-old man with Graves' disease and thyrotoxicosis demonstrated an unusual lateral neck 123I uptake, revealing metastatic papillary thyroid carcinoma that was managed with total thyroidectomy and radioiodine therapy, illustrating that preoperative functional metastases c…
DOI: 10.4158/EP.8.4.304